Application of flax root extract in preparing medicine for preventing and treating hepatitis
A technology of root extract, flax, applied in the field of application in the preparation of drugs for the prevention and/or treatment of hepatitis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0035] The preparation of embodiment 1 flax root extract
[0036] 200 kg of flax (Linum usitatissimum L.) roots were extracted three times with 85% ethanol under reflux, the extracts were combined, and the ethanol was recovered under reduced pressure to obtain a crude extract.
[0037] The crude extract was dissolved in water, then extracted three times with ethyl acetate of the same volume as water, and the ethyl acetate portion was discarded.
[0038] The aqueous layer was extracted three times with the same volume of n-butanol; the n-butanol layers were combined.
[0039] The n-butanol extract was first extracted three times with the same volume of 5% aqueous sodium bicarbonate solution, and then extracted with water until neutral.
[0040] Recover the solvent under reduced pressure to obtain the n-butanol extract, which is the flax root extract.
Embodiment 2
[0041] Embodiment 2, flax root extract acute toxicity study
[0042] (1) Test animals
[0043] ICR mice, male, weighing 18-22 grams, provided by Weitong Lihua Experimental Animal Technology Co., Ltd., certificate number: SCDK (Beijing) 2002-0003
[0044] (2) Test drugs
[0045] Flax root extract, yellow-white powder, stored in the dark at 2-5°C, provided by Professor Qin Hailin of our institute, suspended in 0.5% CMC-Na when used.
[0046] (3) Test method
[0047] Ten mice were orally administered flax root extract at a concentration of 250 mg / ml, and each mouse was administered with a volume of 0.8 ml (ie the highest concentration and maximum volume). Within 7 days after administration, the signs and death of the mice were observed.
[0048] (4) Test results
[0049] After oral administration of flax root extract in mice, the signs did not change significantly. No deaths occurred.
[0050] (5 Conclusion
[0051] Oral administration of flax root extract 10g / kg to mice ...
experiment example 3
[0053] Experimental example 3, the effect of flax root extract on ConA-induced acute liver injury in mice
[0054] (1) Test animals
[0055] ICR mice, male, weighing 18-22 grams, provided by Weitong Lihua Experimental Animal Technology Co., Ltd., certificate number: SCDK (Beijing) 2002-0003
[0056] (2) Test drugs
[0057] Flax root extract, yellow-white powder, stored in the dark at 2-5°C, provided by Professor Qin Hailin of our institute, suspended in 0.5% CMC-Na when used.
[0058] (3) Positive control drug
[0059] Bicyclol, white powder, provided by Peking Union Medical College Pharmaceutical Factory, batch number 20030801, suspended with 0.5% CMC-Na when used.
[0060] 4.ConA
[0061] ConA was purchased from Sigma Corporation.
[0062] (4) Test method
[0063] The animals were randomly divided into 6 groups, 7 animals in each group, which were normal control group, ConA model group, flax root extract high-dose administration group, flax root extract medium-dose adm...
PUM
![No PUM](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka-patsnap-com.libproxy1.nus.edu.sg/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com